Skip to main content

  • From chest pain to coronary functional testing: Clinical and economic impact of coronary microvascular dysfunction

    • Posted: 09/01/2024
    • Author:

      Ilan Merdler, Ryan Wallace, Andrew P. Hill, Kalyan R. Chitturi, Giorgio A. Medranda, Pavan Reddy, Cheng Zhang, Sevket Tolga Ozturk, Vaishnavi Sawant, William S. Weintraub, Kassandra Lopez, Itsik Ben-Dor, Ron Waksman, Hayder D. Hashim and Brian C. Case

    • CRMNews2024

    Abstract

    Background

    Coronary functional testing to formally diagnose coronary microvascular dysfunction (CMD) reduces cardiovascular events and alleviates angina. This study aims to investigate the extensive and complex journey that patients with CMD undergo, from the onset of chest pain to eventual diagnosis.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details